U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07324239) titled 'TECAR Therapy on Pain and Quality of Life in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome' on Dec. 23, 2025.
Brief Summary: Evaluate the effect of TECAR therapy on pain, voiding, erectile function, sleep quality and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome.
Study Start Date: Jan. 02
Study Type: INTERVENTIONAL
Condition:
Prostatitis
Intervention:
DEVICE: TECAR therapy
WINBACK 3SE (France) will be used for TECAR therapy in this study. To facilitate optimal distribution of endogenous heat therapy and effective contact between the active electrodes, both capacitive and resistive, an...